headshot

Karen A. Blindauer, MD

Chief, Professor

Locations

  • Froedtert Hospital
  • Neurosciences - Froedtert Hospital Clinic

Specialties

  • Neurology

Languages

  • English

Contact Information

Education

  • MD - Doctor of Medicine

Biography

Appointments

Adult Division Chief Director, Movement Disorders Program

Specialty

Adult Neurology

Subspecialties

Parkinson's Disease
Essential Tremor
Movement Disorders
Botulinum Toxin Injection for Dystonia
Deep Brain Stimulation (DBS)

Training

Internal Medicine Internship, Medical College of Wisconsin, Milwaukee, WI, 1993 - 1994

Neurology Residency, Medical College of Wisconsin, Milwaukee, WI, 1994 - 1997

Movement Disorders and Experimental Therapeutics Fellowship, University of Rochester, Rochester, NY, 1997 - 1999

Societies

American Academy of Neurology
American Medical Association
Movement Disorders Society

Honors and Awards

Delta Sigma Nu Scholastic Honor Society, 1988
Scott Foundation Scholarship, 1989
Cornelius G. Dyke Award for Excellence in Neurology, 1993
David Fine MD Award for Excellence in Post Graduate Training, 1997
Alpha Omega Alpha Medical Honor Society, 1993
Dystonia Medical Research Foundation, Dystonia Doctor of Excellence Award, 2000
Selected for inclusion in Best Doctors of America

Research Interests

Parkinson's Disease, Dystonia, Essential Tremor, Huntington's Disease

Publications

  • Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

    (Huntington Study Group, Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F Jr, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Chouinard S, Beland M, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E.) JAMA. 2016 Jul 05;316(1):40-50 PMID: 27380342 SCOPUS ID: 2-s2.0-84977592334 07/06/2016

  • A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

    (Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K.) JAMA Neurol. 2014 May;71(5):543-52 PMID: 24664227 SCOPUS ID: 2-s2.0-84900479240 03/26/2014

  • Neural basis for impaired time reproduction in Parkinson's disease: an fMRI study.

    (Elsinger CL, Rao SM, Zimbelman JL, Reynolds NC, Blindauer KA, Hoffmann RG.) J Int Neuropsychol Soc. 2003 Nov;9(7):1088-98 PMID: 14738289 SCOPUS ID: 2-s2.0-0242391756 01/24/2004

  • Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families.

    (Moseley ML, Benzow KA, Schut LJ, Bird TD, Gomez CM, Barkhaus PE, Blindauer KA, Labuda M, Pandolfo M, Koob MD, Ranum LP.) Neurology. 1998 Dec;51(6):1666-71 PMID: 9855520 SCOPUS ID: 2-s2.0-0031647246 12/17/1998

  • Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm.

    (Krouwer HG, Kim TA, Rand SD, Prost RW, Haughton VM, Ho KC, Jaradeh SS, Meyer GA, Blindauer KA, Cusick JF, Morris GL, Walsh PR.) AJNR Am J Neuroradiol. 1998 Oct;19(9):1695-703 PMID: 9802493 SCOPUS ID: 2-s2.0-0343526542 11/05/1998

  • Fulminant progression of demyelinating disease after valproate-induced encephalopathy.

    (Blindauer KA, Harrington G, Morris GL 3rd, Ho KC.) Neurology. 1998 Jul;51(1):292-5 PMID: 9674826 SCOPUS ID: 2-s2.0-0031868351 07/23/1998